top of page
< Back

Raloxifene

雷洛昔芬

Mechanism of action:

Raloxifene 是一種選擇性雌激素受體調節劑(selective estrogen receptor modulator),屬於苯並噻吩類(benzothiophene)衍生物。Raloxifene 可與雌激素受體(estrogen receptor) ERα 與 ERβ 結合,但會誘導受體產生與雌二醇不同的構形變化,而在不同組織產生不同效果。比如抑制破骨細胞(osteoclast)活性,減少骨吸收,增加骨密度;抑制雌激素受體介導的細胞增殖,降低雌激素受體陽性乳癌風險;抑制子宮內膜增生等。

​Reference(s):

1. Heringa M et al. (2003). Review on raloxifene: profile of a selective estrogen receptor modulator. Int J Clin Pharmacol Ther. 


2. Cummings SR et al. (1999). The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. JAMA. 


3. Bryant HU et al. (1999). An estrogen receptor basis for raloxifene action in bone. J Steroid Biochem Mol Biol.

bottom of page